InMed Pharmaceuticals Inc. (MTRI) income statement
MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM
$18.60+0.25 (+1.36%)
Close on Nov 13, 2026Market cap $102.18MP/E –Yield –
InMed Pharmaceuticals Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2026
- -173.1%
Financial strength
- Current ratio
- –
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- –
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?